MedTrace Logo

Opioids in Chronic Kidney Disease Patients Undergoing Hemodialysis

NCT02452437 · Status: UNKNOWN · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2015-05-22

No results posted yet for this study

Summary

To measure oxycodone's intradialytic mass transfer rate coefficient and oxycodone's removal rate using an ODE/PDE hemodialysis model. To implement a rational clinical strategy for estimating a patient's post-hemodialysis oxycodone restoration dose using results from an ODE/PDE model of hemodialysis.

Conditions

Interventions

DRUG

Oxycodone

Controlled release oxycodone 40 mg twice daily

Sponsors & Collaborators

  • Emerio & Lourdes Linares Research and Education Center

    lead OTHER

Principal Investigators

  • Oscar A Linares, MD · Emerio & Lourdes Linares Research and Education Center

Study Design

Allocation
NON_RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
30 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2015-05-31
Primary Completion
2015-09-30
Completion
2015-12-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02452437 on ClinicalTrials.gov